CM
ITCI
Caption Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1113 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1185 |
|
|
2024
Q3 | – | Sell |
-618
| Closed | -$42.3K | – | 920 |
|
|
2024
Q2 | $42.3K | Sell |
618
-266,162
| -100% | -$18.2M | ﹤0.01% | 347 |
|
|
2024
Q1 | $18.5M | Buy |
266,780
+226,783
| +567% | +$15.7M | 0.28% | 8 |
|
|
2023
Q4 | $2.86M | Buy |
+39,997
| New | +$2.86M | 0.04% | 66 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 860 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 820 |
|
|
2023
Q1 | – | Sell |
-12,205
| Closed | -$646K | – | 900 |
|
|
2022
Q4 | $646K | Buy |
12,205
+5,500
| +82% | +$291K | 0.01% | 187 |
|
|
2022
Q3 | $312K | Buy |
+6,705
| New | +$312K | ﹤0.01% | 290 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 965 |
|
|
2022
Q1 | – | Sell |
-17,144
| Closed | -$898K | – | 1056 |
|
|
2021
Q4 | $898K | Sell |
17,144
-26,235
| -60% | -$1.37M | 0.01% | 278 |
|
|
2021
Q3 | $1.62M | Buy |
43,379
+33,319
| +331% | +$1.24M | 0.02% | 194 |
|
|
2021
Q2 | $411K | Buy |
10,060
+2,260
| +29% | +$92.3K | 0.01% | 282 |
|
|
2021
Q1 | $265K | Sell |
7,800
-23,700
| -75% | -$805K | 0.01% | 269 |
|
|
2020
Q4 | $1M | Sell |
31,500
-28,173
| -47% | -$896K | 0.02% | 121 |
|
|
2020
Q3 | $1.53M | Buy |
59,673
+6,623
| +12% | +$170K | 0.04% | 88 |
|
|
2020
Q2 | $1.36M | Buy |
+53,050
| New | +$1.36M | 0.05% | 88 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 614 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 557 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 519 |
|
|
2019
Q2 | – | Sell |
-80,000
| Closed | -$975K | – | 477 |
|
|
2019
Q1 | $975K | Buy |
+80,000
| New | +$975K | 0.05% | 82 |
|